Clostridium difficile Infection clinical trials
19 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Fecal Microbiota Transplantation for C Diff Infection
- Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
- Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
- Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)
- Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
- Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile
- MTC Versus FMT in for RCDI
- VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.
- Fecal Microbiota Transplant National Registry
- Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
- Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
- Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
- Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy
- Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
- LMN-201 for Prevention of C. Difficile Infection Recurrence
- Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
- Evaluation of GeoHAI Implementation
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Clostridium difficile Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.